Clinical trial
Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE)
NCT00065806 · Laura Schanberg, Other · Completed
Key facts
| NCT number | NCT00065806 |
|---|---|
| Title | Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Test the Safety and Efficacy of Lipitor (Atorvastatin) in Reducing the Progression of Carotid IMT in Early Childhood SLE |
| Lead sponsor | Laura Schanberg, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lupus Erythematosus, Systemic |
| Intervention type | Drug |
| Interventions | Atorvastatin, Placebo atorvastatin |
| Enrollment | 221 |
| Start date | Sep 1, 2003 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Aug 4, 2003 |
| Last update posted | Aug 15, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: